239 related articles for article (PubMed ID: 25763784)
1. Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract.
Michel KG; Huijbregts RP; Gleason JL; Richter HE; Hel Z
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):511-8. PubMed ID: 25763784
[TBL] [Abstract][Full Text] [Related]
2. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
Front Immunol; 2021; 12():760504. PubMed ID: 34956191
[TBL] [Abstract][Full Text] [Related]
4. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
Achilles SL; Meyn LA; Mhlanga FG; Matubu AT; Stoner KA; Beamer MA; Chirenje ZM; Hillier SL
Am J Reprod Immunol; 2020 Sep; 84(3):e13287. PubMed ID: 32533883
[TBL] [Abstract][Full Text] [Related]
5. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
6. Immediate start of hormonal contraceptives for contraception.
Lopez LM; Newmann SJ; Grimes DA; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD006260. PubMed ID: 23235628
[TBL] [Abstract][Full Text] [Related]
7. Immediate start of hormonal contraceptives for contraception.
Lopez LM; Newmann SJ; Grimes DA; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2008 Apr; (2):CD006260. PubMed ID: 18425943
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
Thurman A; Chandra N; Schwartz JL; Brache V; Chen BA; Asin S; Rollenhagen C; Herold BC; Fichorova RN; Hillier SL; Weiner DH; Mauck C; Doncel GF
AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
van de Wijgert JH; Verwijs MC; Turner AN; Morrison CS
AIDS; 2013 Aug; 27(13):2141-53. PubMed ID: 23660575
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
11. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
13. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
[TBL] [Abstract][Full Text] [Related]
14. Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
Deese J; Masson L; Miller W; Cohen M; Morrison C; Wang M; Ahmed K; Agot K; Crucitti T; Abdellati S; Van Damme L
Am J Reprod Immunol; 2015 Oct; 74(4):357-67. PubMed ID: 26202107
[TBL] [Abstract][Full Text] [Related]
15. The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis.
Torok MR; Miller WC; Hobbs MM; Macdonald PD; Leone PA; Schwebke JR; Seña AC
Sex Transm Dis; 2009 Jun; 36(6):336-40. PubMed ID: 19556926
[TBL] [Abstract][Full Text] [Related]
16. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
17. Differential Elevation of Inflammation and CD4
Omollo K; Lajoie J; Oyugi J; Wessels JM; Mwaengo D; Kimani J; Kaushic C; Fowke KR
Front Immunol; 2020; 11():598307. PubMed ID: 33717049
[TBL] [Abstract][Full Text] [Related]
18. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
[TBL] [Abstract][Full Text] [Related]
19. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
20. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
